Dermal Fillers Market Size, Share, Opportunities, And Trends By Product Type (Biodegradable, Non-biodegradable), By Application (Facial Line Correction, Face Lift, Lip Enhancement, Others), By Material (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres, Others), By End-User (Dermatology Clinics, Hospitals, Others), And By Geography - Forecasts From 2023 To 2028

  • Published : May 2023
  • Report Code : KSI061614648
  • Pages : 165

The dermal fillers market is projected to grow at a CAGR of 8.57%, reaching US$5.597 billion in 2028 from US$3.148 billion in 2021.

Dermal fillers are cosmetic injections given to customers seeking to enhance and alter the current appearance of their faces. Dermal fillers are a standard procedure opted for by consumers who wish to reduce the sagging appearance of their facial skin, uplift the facial appearance, increase the mass, or enhance the symmetry of their facial features such as cheeks, lips, and jawlines. An extensive range of different types of dermal fillers is available for consumers through dermatology clinics, hospitals, and medical spas. The customers can notice immediate results, and based on the type of dermal filler opted for, the results might be effective for a few months or years.

Dermal fillers are gaining popularity due to their efficiency in restoring the aging signs of the patient's skin and adding extra volume to the targeted facial part. For instance, the Juvederm dermal filler by Kaya Clinic in India guarantees immediate results to its customers within one week of injecting it into the skin. Various skin concern factors such as sun damage, fine lines, wrinkles, sunken eyes, and skin discoloration resulting from the loss of volume in the face tissues. By injecting dermal fillers, the user can benefit from reducing the appearance of all such skin concerns. Apart from this, the dermal fillers help construct collagen and elastin content in the injected area, which are beneficial to restore the skin's health. Even though there are several skincare products and regimens which can be opted for by consumers, the result offered by dermal fillers is of superior quality, due to which the international dermal fillers market is witnessing an increased market size.

An increasing number of low-risk non-surgical, and minimally invasive procedures are expected to boost the market growth. 

The dermal fillers injected into the patient's skin are non-surgical procedures. Therefore, it is a minimally invasive procedure that does not require its customer to undergo a cosmetic operation or receive anaesthesia to achieve the desired outcome. The annual report released by The Aesthetic Society highlighted that the number of dermal filler procedures in 2021 amounted to approximately 1.8 million, whereas other skin tightening treatment procedures amounted to 0.39 million. This demonstrates interest in dermal fillers owing to their various face enhancement benefits and low-risk features. Therefore, considering these key factors driving demand for the dermal filler market, it can be anticipated that it will continue to expand its market size over the forecast period.

The intense competition offered by similar cosmetic procedures will likely restrain the growth of the dermal fillers market.

Apart from dermal fillers, there are several cosmetic procedures and skin care services that provide similar results as dermal fillers. Botox, radio frequency-based face treatments, laser skin resurfacing method, micro-needling, and other facial revitalization treatments. Apart from these existing methods, pharmaceutical and skincare brands regularly innovate new techniques and treatments. For instance, ForeverSlender Medspa, a skin clinic based in the USA, has innovated a new non-surgical alternative for dermal fillers named Ultralift. Therefore, the existence of other options for derma fillers has the potential to slow down the expansion of the dermal fillers market.

Market Developments:

  • In June 2022, Croma Aesthetics Canada Ltd. introduced a new derma filler product, Saypha Volume Plus, with hyaluronic acid as its vital ingredient under its subsidiary brand Hugel Aesthetics. This derma filler targets restoring the original volume of the face.
  • In June 2021, Medytox Inc. expanded its operations to Taiwan and announced a collaboration with Dynamic Medical Technologies Company to manufacture hyaluronic-acid-based dermal fillers.
  • In February 2020, BioScience GmbH, specializing in the manufacture of aesthetic cosmetology products, introduced a new product line consisting of two new derma fillers of varying density levels.

North America is expected to hold a significant share of the universal dermal fillers market.

The increase in minimally-invasive cosmetic procedures across North American countries and the rise in skin clinic services and aesthetics are resulting in high demand and consumption of dermal fillers. Furthermore, the rising need for derma fillers and other cosmetic treatments is attracting branches of foreign companies into the North American market. For instance, Amalian, a German company specializing in high-end healthcare and skincare products, has announced its clinic's launch and superior-quality dermal fillers in Canada. In addition, healthcare and beauty companies in North America are actively investing in launching new products, including dermal fillers. For instance, AbbVie Company, a US-based pharmaceutical company, has been developing and launching new dermal filler product lines through its subsidiary brand, Allergan Aesthetics. Therefore, considering the factors influencing the rapid market growth of dermal fillers in North America, it can be anticipated that North America will experience expansion in the dermal fillers market.

Dermal Fillers Market Scope:


Report Metric Details
Market Size Value in 2021 US$3.148 billion
Market Size Value in 2028 US$5.597 billion
Growth Rate CAGR of 8.57% from 2021 to 2028
Base Year 2021
Forecast Period 2023 – 2028
Forecast Unit (Value) USD Billion
Segments Covered Product Type, Application, Material, End-User, and Geography
Regions Covered North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered Sinclair, Suneva Medical, Merz Pharma, Abbvie Inc. (ALLEGRAN), Galderma Laboratories, L.P., Croma Pharma, Cytophil, Inc., Humedix, Prollenium Medical Technologies
Customization Scope Free report customization with purchase


Market Segmentation:

  • By Product Type
    • Biodegradable
    • Non-biodegradable
  • By Application
    • Facial Line Correction
    • Face Lift
    • Lip Enhancement
    • Others
  • By Material
    • Hyaluronic Acid
    • Calcium Hydroxylapatite
    • Poly-L-Lactic Acid
    • Polymethyl-Methacrylate Microspheres
    • Others
  • By End-User
    • Dermatology Clinics
    • Hospitals
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Vietnam
      • Others

Frequently Asked Questions (FAQs)

The global dermal fillers market is projected to grow at a CAGR of 8.57% during the forecast period.
The dermal fillers market is projected to reach a total market size of US$5.597 billion by 2028.
Dermal Fillers Market was valued at US$3.148 billion in 2021.
An increasing number of low-risk non-surgical and minimally invasive procedures are expected to boost the dermal fillers market growth.
North America is expected to hold a notable share of the global dermal fillers market.


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline


2.1. Research Data

2.2. Research Design

2.3. Validation


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Biodegradable

5.3. Non- Biodegradable


6.1. Introduction

6.2. Facial Line Correction 

6.3. Face Lift

6.4. Lip Enhancement

6.5. Others


7.1. Introduction

7.2. Hyaluronic Acid

7.3. Calcium Hydroxylapatite

7.4. Poly-L-Lactic Acid 

7.5. Polymethyl-Methacrylate Microspheres

7.6. Others


8.1. Introduction

8.2. Dermatology Clinics

8.3. Hospitals

8.4. Others


9.1. Introduction

9.2. Face

9.3. Full body


10.1. Introduction 

10.2. North America

10.2.1. USA

10.2.2. Canada

10.2.3. Mexico

10.3. South America

10.3.1. Brazil

10.3.2. Argentina

10.3.3. Others

10.4. Europe

10.4.1. Germany

10.4.2. France

10.4.3. United Kingdom

10.4.4. Spain

10.4.5. Others

10.5. Middle East And Africa

10.5.1. Saudi Arabia

10.5.2. UAE

10.5.3. Israel

10.5.4. Others

10.6. Asia Pacific

10.6.1. China

10.6.2. Japan

10.6.3. India

10.6.4. South Korea

10.6.5. Indonesia

10.6.6. Thailand

10.6.7. Vietnam

10.6.8. Others


11.1. Major Players and Strategy Analysis

11.2. Emerging Players and Market Lucrativeness

11.3. Mergers, Acquisitions, Agreements, and Collaborations

11.4. Vendor Competitiveness Matrix


12.1. Sinclair

12.2. Suneva Medical

12.3. Merz Pharma

12.4. Abbvie Inc. (ALLEGRAN)

12.5. Galderma Laboratories, L.P.

12.6. Croma Pharma

12.7. Cytophil, Inc.

12.8. Humedix

12.9. Prollenium Medical Technologies


Suneva Medical

Merz Pharma

Abbvie Inc. (ALLEGRAN)

Galderma Laboratories, L.P.

Croma Pharma

Cytophil, Inc.


Prollenium Medical Technologies